Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Matt Winkler, Evan Jones

Premium

Molecular diagnostic company Asuragen has appointed Rollie Carlson to president and CEO, replacing founder Matt Winkler, who will retain the role of chairman of the board and chief scientific officer.

Carlson was previously the president and chief operating officer of Asuragen. Prior to joining the company in 2006, he held several positions at Abbott Laboratories, including vice president and general manager of the Vysis molecular diagnostic business following its acquisition by Abbott.


Foundation Medicine has appointed Evan Jones to its board of directors. He is managing member of jVen Capital and was previously the co-founder, chairman, and CEO of Digene.

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.